bpc 157 vision Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions The Hidden Risks of BPC‑157:

The agency flagged three adverse events in its FAERS database tied to compounded injectable BPC-157, including a case in which a patient developed diffuse hyperpigmentation and gingival darkening after using a blended BPC-157/TB-500 product labeled "research purposes only." The safety concern most specific to BPC-157 is its mechanism of action

Intravenous Injection : Direct bloodstream entry providing fastest onset

Many people begin with weekly shots, especially if they're experiencing significant fatigue or B12 deficiency

Individuals with known hypersensitivity to ascorbic acid, those with a history of oxalate kidney stones, G6PD deficiency, iron overload disorders, or severe renal impairment should avoid this product

For these cases, a vet can take a blood sample to understand the extent of the deficiency